1-3 of 3
Miriam Puttini
Close
Sort by
Journal Articles

Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years,

Carlo Gambacorti-Passerini, MD, Laura Antolini, Rocco Piazza, MD, PhD, François Guilhot, Michael Deininger, MD, PhD, Carmen Fava, Arnon Nagler, Enrica Morra, Elisabetta Abruzzese, Anna D'Emilio, Fabio Stagno, Philipp D. le Coutre, MD, Rafael Hurtado Monroy, MD, Valeria Santini, MD, Fabrizio Pane, Pilar Giraldo, Sarit Assouline, MD, Muheez A Durosinmi, MD, Onno Leeksma, MD, DPhil, Enrico Maria Pogliani, MD, Francesca Pavesi, Miriam Puttini, PhD, Christian Rizzo, Ilaria Dilda, Silvia Mori, PhD, Dong-Wook Kim, MD, PhD, Maria Grazia Valsecchi
Journal: Blood
Blood (2011) 118 (21): 3766.
https://doi.org/10.1182/blood.V118.21.3766.3766
Published: 2011
Journal Articles

NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma

Annamaria Galietta, Rosalind H. Gunby, Sara Redaelli, Paola Stano, Cristiana Carniti, Angela Bachi, Philip W. Tucker, Carmen J. Tartari, Ching-Jung Huang, Emanuela Colombo, Karen Pulford, Miriam Puttini, Rocco G. Piazza, Holger Ruchatz, Antonello Villa, Arianna Donella-Deana, Oriano Marin, Danilo Perrotti, Carlo Gambacorti-Passerini
Journal: Blood
Blood (2007) 110 (7): 2600–2609.
https://doi.org/10.1182/blood-2006-01-028647
Published: 2007
Includes: Supplemental data
Journal Articles

In Vitro and In Vivo Activity of SKI-606, a Novel Abl/Src Inhibitor, Against Imatinib Resistant BCR-ABL+ Neoplastic Cells.

Miriam Puttini, Addolorata M.L. Coluccia, Frank Boschelli, Anna Franceschino, Lucia Tornaghi, Shaheen Ahmed, Sara Redaelli, Rocco Piazza, Vera Magistroni, Federica Andreoni, Leonardo Scapozza, Franca Formelli, Carlo Gambacorti
Journal: Blood
Blood (2006) 108 (11): 2176.
https://doi.org/10.1182/blood.V108.11.2176.2176
Published: 2006